Table 1 Patient characteristics at inclusion
Phytalgic® | Placebo | |
|---|---|---|
Total number of subjects | 41 | 40 |
Male/female | 14/27 | 12/28 |
Mean Age (range), years | 56.8 (28 to 79) | 57.5 (28 to 84) |
Osteoarthritis (n) | ||
One knee | 13 | 21 |
Two knees | 12 | 8 |
One hip | 8 | 5 |
Two hips | 3 | 4 |
Knees and hips | 5 | 2 |
WOMAC scores at inclusion (mean ± SD) | ||
Pain score | 215.7 ± 88.0 | 229.5 ± 112.1 |
Stiffness score | 98.6 ± 50.6 | 97.9 ± 63.2 |
Function score** | 688.8 ± 281.0 | 689.0 ± 368.9 |
Total score** | 1000.8 ± 391.5 | 1014.6 ± 526.8 |
Ongoing treatment (n) | ||
Analgesics (number of users, tablets/week ± SD) | 34 (19.8 ± 12.7) | 35 (19.1 ± 14.4) |
Single-component Paracetamol | 12 (21 ± 14.7) | 15 (15.4 ± 10.4) |
Combined Paracetamol | 19 (15.6 ± 10.9) | 17 (15.1 ± 12.1) |
NSAIDs: n (DDD ± SD) | 23 (1.3 ± 0.9) | 23 (1.1 ± 1.1) |
OA Treatment*: n (DDD ± SD) | 16 (1.1 ± 0.5) | 12 (0.9 ± 0.4) |